Tim D. Holmes

1.8k total citations · 1 hit paper
11 papers, 1.0k citations indexed

About

Tim D. Holmes is a scholar working on Immunology, Hematology and Genetics. According to data from OpenAlex, Tim D. Holmes has authored 11 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Immunology, 2 papers in Hematology and 2 papers in Genetics. Recurrent topics in Tim D. Holmes's work include Immune Cell Function and Interaction (10 papers), T-cell and B-cell Immunology (6 papers) and Virus-based gene therapy research (2 papers). Tim D. Holmes is often cited by papers focused on Immune Cell Function and Interaction (10 papers), T-cell and B-cell Immunology (6 papers) and Virus-based gene therapy research (2 papers). Tim D. Holmes collaborates with scholars based in United Kingdom, Sweden and Norway. Tim D. Holmes's co-authors include Yenan T. Bryceson, Graham P. Cook, Samuel C. C. Chiang, Kristin Mattsson, Hans‐Gustaf Ljunggren, Bianca Tesi, Jeffrey S. Miller, Vivien Béziat, Hongya Han and Marie Schaffer and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Immunity and Nature Immunology.

In The Last Decade

Tim D. Holmes

11 papers receiving 1.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cytomegalovirus Infection Drives Adaptive Epigenetic Diversification of NK Cells with Altered Signaling and Effector Function

2015 551 citations Heinrich Schlums, Frank Cichocki et al. Immunity profile →

Peers

Countries citing papers authored by Tim D. Holmes

Since Specialization

Citations

This map shows the geographic impact of Tim D. Holmes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tim D. Holmes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tim D. Holmes more than expected).

Fields of papers citing papers by Tim D. Holmes

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tim D. Holmes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tim D. Holmes. The network helps show where Tim D. Holmes may publish in the future.

Co-authorship network of co-authors of Tim D. Holmes

This figure shows the co-authorship network connecting the top 25 collaborators of Tim D. Holmes. A scholar is included among the top collaborators of Tim D. Holmes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tim D. Holmes. Tim D. Holmes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

#	Work	Indexed citations
1	Herring roe oil in treatment of psoriasis – influence on immune cells and cytokine network 2023 ·Frontiers in Immunology ·Aleksandra Petrovič, (unknown), Kåre Steinar Tveit, (unknown), Bodil Bjørndal, Tim D. Holmes, Richard Davies, Karl A. Brokstad, Brith Bergum, Silke Appel	2
2	Oncolytic virus treatment differentially affects the CD56^dim and CD56^bright NK cell subsets in vivo and regulates a spectrum of human NK cell activity 2022 ·Immunology ·Michelle Wantoch, Erica Wilson, Alastair Droop, (unknown), Matt Coffey, Yasser M. El‐Sherbiny, Tim D. Holmes, Alan Melcher, Laura F. Wetherill, Graham P. Cook	6
3	NK cell receptor NKG2D sets activation threshold for the NCR1 receptor early in NK cell development 2018 ·Nature Immunology ·Vedrana Jelenčić, Marko Šestan, Inga Kavazović, (unknown), Sonja Marinović, Tim D. Holmes, Michaela Prchal‐Murphy, Berislav Lisnić, Veronika Sexl, Yenan T. Bryceson, Felix M. Wensveen, Bojan Polić	46
4	Phosphorylation of intracellular signalling molecules in peripheral blood cells from patients with psoriasis on originator or biosimilar infliximab 2017 ·British Journal of Dermatology ·(unknown), (unknown), Richard Davies, (unknown), Tim D. Holmes, Sonia Gavasso, Yenan T. Bryceson, Roland Jonsson, (unknown), Silke Appel	6
5	Natural killer cell memory in context 2016 ·Seminars in Immunology ·Tim D. Holmes, Yenan T. Bryceson	22
6	Cytomegalovirus Infection Drives Adaptive Epigenetic Diversification of NK Cells with Altered Signaling and Effector Function breakdown → 2015 ·Immunity ·Heinrich Schlums, Frank Cichocki, Bianca Tesi, Jakob Theorell, Vivien Béziat, Tim D. Holmes, Hongya Han, Samuel C. C. Chiang, Bree Foley, Kristin Mattsson, Stella Larsson, Marie Schaffer, Karl‐Johan Malmberg, Hans‐Gustaf Ljunggren, Jeffrey S. Miller, Yenan T. Bryceson	551
7	Licensed human natural killer cells aid dendritic cell maturation via TNFSF14/LIGHT 2014 ·Proceedings of the National Academy of Sciences ·Tim D. Holmes, Erica Wilson, Emma Black, Andrew V. Benest, Candida Vaz, Betty Tan, Vivek Tanavde, Graham P. Cook	57
8	Controlled infection with a therapeutic virus defines the activation kinetics of human natural killer cellsin vivo 2014 ·Clinical & Experimental Immunology ·Yasser M. El‐Sherbiny, Tim D. Holmes, Laura F. Wetherill, Emma Black, Erica Wilson, (unknown), Gina B. Scott, R Adair, Rajiv Dave, Karen J. Scott, (unknown), Matthew Coffey, Giles J. Toogood, Alan Melcher, Graham P. Cook	22
9	A Human NK Cell Activation/Inhibition Threshold Allows Small Changes in the Target Cell Surface Phenotype To Dramatically Alter Susceptibility to NK Cells 2010 ·The Journal of Immunology ·Tim D. Holmes, Yasser M. El‐Sherbiny, Adam Davison, (unknown), G. Eric Blair, Graham P. Cook	46
10	Proteolytic Activation of the Cytotoxic Phenotype during Human NK Cell Development 2009 ·The Journal of Immunology ·Josephine Meade, Erica Wilson, Tim D. Holmes, Erika A. de Wynter, Peter Brett, (unknown), (unknown), Joseph A. Trapani, Michael McDermott, Graham P. Cook	18
11	The Requirement for DNAM-1, NKG2D, and NKp46 in the Natural Killer Cell-Mediated Killing of Myeloma Cells 2007 ·Cancer Research ·Yasser M. El‐Sherbiny, Josephine Meade, Tim D. Holmes, Dennis McGonagle, Sarah Mackie, Ann W Morgan, Gordon Cook, Sylvia Feyler, Stephen J. Richards, Faith E. Davies, Gareth J. Morgan, Graham P. Cook	264

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact